Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Sr Care Pharm ; 39(6): 228-234, 2024 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-38803026

RESUMO

Background Recent cardiovascular guideline updates recommend against the use of aspirin for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in older people. However, aspirin use remains common in this population. Objective To implement and evaluate the benefit of a pharmacist-driven aspirin deprescribing protocol compared with primary care provider (PCP) education-only in a primary care setting. Methods This prospective, cohort project targeted deprescribing for patients prescribed aspirin for primary prevention of ASCVD. Patients were included if they received primary care services at the Milwaukee Veterans Health Administration Medical Center (VHA) and were 70 years of age or older. Criteria for exclusion were aspirin obtained outside the VHA system, aspirin prescribed for a non-ASCVD-related condition, and/or a history of ASCVD. Active deprescribing by pharmacists and PCP education took place in the intervention group with PCP education only in the standard-of-care group. The primary outcome was the proportion of patients who had aspirin deprescribed in each group. Secondary outcomes included patient acceptability of the intervention and barriers to implementation. Results A total of 520 patients were prescribed aspirin in the intervention group versus 417 in the education-only group. Sixty-five patients met intervention criteria and were contacted for aspirin deprescribing. The pharmacist-led active deprescribing group led to a higher rate of aspirin deprescriptions versus the education-only group (54% vs 18%; P = 0.0001) for patients who met criteria. Conclusion A pharmacist-led aspirin deprescribing protocol within a primary care setting significantly decreased the number of aspirin prescriptions compared with PCP education only.


Assuntos
Aspirina , Desprescrições , Farmacêuticos , Atenção Primária à Saúde , Veteranos , Humanos , Aspirina/uso terapêutico , Aspirina/administração & dosagem , Idoso , Feminino , Masculino , Estudos Prospectivos , Idoso de 80 Anos ou mais , Estudos de Coortes , Prevenção Primária/métodos , Estados Unidos , Aterosclerose/tratamento farmacológico , Aterosclerose/prevenção & controle
2.
J Palliat Med ; 27(6): 784-788, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38466991

RESUMO

Background: Palliative PLUS (PP) at the Minneapolis Veterans Affairs Health Care System (MVAHCS) is an interdisciplinary team that seeks to improve veteran access to palliative and hospice resources. Palliative care pharmacists were incorporated to increase patient access to palliative specialties. Objective: To identify and categorize pharmacist interventions within an outpatient PP team at the MVAHCS. Methods: This quality improvement project was a retrospective analysis of the electronic health record. Results: A total of 84 patients were participating in the PP program over 13 months. Among those patients, 25 had pharmacist involvement and a total of 56 interventions were identified. Of those interventions, 29 (51.8%) were direct interventions and 27 (48.2%) were curbside consults. Most interventions involved medication counseling and medication adherence. Conclusion: Pharmacists made an impact on the PP team through direct patient interventions involving medication counseling and aided the interdisciplinary team by facilitating patient medication adherence.


Assuntos
Hospitais de Veteranos , Cuidados Paliativos , Farmacêuticos , United States Department of Veterans Affairs , Humanos , Estudos Retrospectivos , Masculino , Feminino , Estados Unidos , Idoso , Equipe de Assistência ao Paciente/organização & administração , Pessoa de Meia-Idade , Melhoria de Qualidade , Idoso de 80 Anos ou mais , Veteranos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA